{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-22-000016","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2022-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.909912+00:00","generated_at":"2026-06-27T05:57:39.302358+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Penumbra Q4 2021 revenue $204M (+22% YoY); GAAP op loss $40.1M, adjusted op income $2.5M","bullets":["Q4 revenue $204.0M (+22.2% YoY; +23.0% constant currency); US $144.5M (+23.7%).","Vascular revenue $113.6M (+30.4%); neuro revenue $90.4M (+13.3%).","GAAP operating loss $40.1M; non-GAAP op income $2.5M excluding $25.8M Sixense accelerated vesting and $15.0M Thunderbolt R&D milestone.","Full year 2021 revenue $747.6M (+33.4%); non-GAAP op income $40.1M vs prior year loss of $22.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-22-000016","json":"https://secwatch.observer/filing/0001321732-22-000016.json","markdown":"https://secwatch.observer/filing/0001321732-22-000016.md","text":"https://secwatch.observer/filing/0001321732-22-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173222000016/0001321732-22-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173222000016/pen-20220222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:57:39.302358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}